William N. Charman

19.2k total citations · 6 hit papers
170 papers, 14.8k citations indexed

About

William N. Charman is a scholar working on Oncology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, William N. Charman has authored 170 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 48 papers in Molecular Biology and 38 papers in Pharmaceutical Science. Recurrent topics in William N. Charman's work include Drug Transport and Resistance Mechanisms (42 papers), Drug Solubulity and Delivery Systems (33 papers) and Malaria Research and Control (20 papers). William N. Charman is often cited by papers focused on Drug Transport and Resistance Mechanisms (42 papers), Drug Solubulity and Delivery Systems (33 papers) and Malaria Research and Control (20 papers). William N. Charman collaborates with scholars based in Australia, United States and Switzerland. William N. Charman's co-authors include Christopher J. H. Porter, Natalie L. Trevaskis, Susan A. Charman, Colin W. Pouton, Andrew Humberstone, Valentino J. Stella, Glenn A. Edwards, Ben J. Boyd, Hywel D. Williams and Ann Marie Kaukonen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

William N. Charman

169 papers receiving 14.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

2007 1.4k citations Christopher J. H. Porter, Natalie L. Trevaskis et al. profile →
Strategies to Address Low Drug Solubility in Discovery and Development

2013 1.3k citations Natalie L. Trevaskis, Susan A. Charman et al. profile →
Enhancing intestinal drug solubilisation using lipid-based delivery systems

2007 580 citations Christopher J. H. Porter, William N. Charman et al. Advanced Drug Delivery Reviews profile →
Identification of an antimalarial synthetic trioxolane drug development candidate

2004 507 citations Jonathan L. Vennerstrom, Reto Brun et al. profile →
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH

1997 480 citations William N. Charman, Christopher J. H. Porter et al. Journal of Pharmaceutical Sciences profile →
50 years of oral lipid-based formulations: Provenance, progress and future perspectives

2016 340 citations Natalie L. Trevaskis, William N. Charman et al. Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by William N. Charman

Since Specialization

Citations

This map shows the geographic impact of William N. Charman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William N. Charman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William N. Charman more than expected).

Fields of papers citing papers by William N. Charman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William N. Charman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William N. Charman. The network helps show where William N. Charman may publish in the future.

Co-authorship network of co-authors of William N. Charman

This figure shows the co-authorship network connecting the top 25 collaborators of William N. Charman. A scholar is included among the top collaborators of William N. Charman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William N. Charman. William N. Charman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacy and Pharmaceutical Sciences 2015 ·William N. Charman	8
2	Label-Free Kinetics: Exploiting Functional Hemi-Equilibrium to Derive Rate Constants for Muscarinic Receptor Antagonists 2015 ·Molecular Pharmacology ·Darren Riddy, Céline Valant, Patricia Rueda, William N. Charman, Patrick M. Sexton, Roger J. Summers, Arthur Christopoulos, Christopher J. Langmead	17
3	Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth 2010 ·Journal of Medicinal Chemistry ·Ken D. Johnstone, Tomislav Karoli, Ligong Liu, Keith Dredge, (unknown), Cai Ping Li, Kat Davis, Edward Hammond, Ian Bytheway, Edmund Kostewicz, Francis C. K. Chiu, David M. Shackleford, Susan A. Charman, William N. Charman, Job Harenberg, Thomas J. Gonda, Vito Ferro	64
4	Lymphatic Transport of Methylnortestosterone Undecanoate (MU) and the Bioavailability of Methylnortestosterone Are Highly Sensitive to the Mass of Coadministered Lipid after Oral Administration of MU 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Karen L. White, (unknown), William N. Charman, Glenn A. Edwards, (unknown), Christopher J. H. Porter	17
5	Quantum chemical study of the intermediate complex required for iron-mediated reactivity and antimalarial activity of dispiro-1,2,4-trioxolanes 2008 ·Journal of Molecular Graphics and Modelling ·Darren J. Creek, David K. Chalmers, William N. Charman, Brian J. Duke	8
6	Pharmacy Education in the Context of Australian Practice 2008 ·American Journal of Pharmaceutical Education ·Jennifer Marriott, Roger L. Nation, Louis Roller, (unknown), Kirsten Galbraith, Peter Stewart, William N. Charman	90
7	Probing the Flexibility of the DsbA Oxidoreductase from Vibrio cholerae—a 15N - 1H Heteronuclear NMR Relaxation Analysis of Oxidized and Reduced Forms of DsbA 2007 ·Journal of Molecular Biology ·James Horne, Edward J. d’Auvergne, M.P. Coles, Tony Velkov, Yanni K.‐Y. Chin, William N. Charman, Richard J. Prankerd, Paul R. Gooley, M.J. Scanlon	19
8	An Acute and Coincident Increase in FABP Expression and Lymphatic Lipid and Drug Transport Occurs During Intestinal Infusion of Lipid-Based Drug Formulations to Rats 2006 ·Pharmaceutical Research ·Natalie L. Trevaskis, Chun‐Min Lo, Yun Li, Patrick Tso, Helen Irving, Christopher J. H. Porter, William N. Charman	7
9	The Lymph Lipid Precursor Pool Is a Key Determinant of Intestinal Lymphatic Drug Transport 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Natalie L. Trevaskis, Christopher J. H. Porter, William N. Charman	38
10	Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidine 2006 ·Bioorganic & Medicinal Chemistry Letters ·Maniyan P. Padmanilayam, Bernard Scorneaux, Yuxiang Dong, Jacques Chollet, Hugues Matile, Susan A. Charman, Darren J. Creek, William N. Charman, (unknown), Christian Scheurer, Sergio Wittlin, Reto Brun, Jonathan L. Vennerstrom	49
11	Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin 2005 ·Journal of Pharmaceutical Sciences ·Susan A. Charman, (unknown), Francis C. K. Chiu, Kylie A. McIntosh, Richard J. Prankerd, William N. Charman	25
12	Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine 2004 ·Journal of Pharmaceutical Sciences ·Christopher J. H. Porter, Ann Marie Kaukonen, (unknown), Ben J. Boyd, (unknown), Glenn A. Edwards, William N. Charman	185
13	Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations 2004 ·Pharmaceutical Research ·Ann Marie Kaukonen, Ben J. Boyd, Christopher J. H. Porter, William N. Charman	181
14	Using the Polymer Partitioning Method to Probe the Thermodynamic Activity of Poorly Water‐soluble Drugs Solubilized in Model Lipid Digestion Products 2003 ·Journal of Pharmaceutical Sciences ·Ben J. Boyd, Christopher J. H. Porter, William N. Charman	17
15	Contribution of Lymphatically Transported Testosterone Undecanoate to the Systemic Exposure of Testosterone after Oral Administration of Two Andriol Formulations in Conscious Lymph Duct-Cannulated Dogs 2003 ·Journal of Pharmacology and Experimental Therapeutics ·David M. Shackleford, (unknown), Natalie Houwing, (unknown), Glenn A. Edwards, Christopher J. H. Porter, William N. Charman	88
16	In vitro assessment of oral lipid based formulations 2001 ·Advanced Drug Delivery Reviews ·Christopher J. H. Porter, William N. Charman	318
17	Lipids, Lipophilic Drugs, and Oral Drug Delivery—Some Emerging Concepts 2000 ·Journal of Pharmaceutical Sciences ·William N. Charman	168
18	The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment 2000 ·International Journal of Pharmaceutics ·Shui‐Mei Khoo, Christopher J. H. Porter, William N. Charman	67
19	Variation in the diffusion and release of ribonuclease through and from esterified hyaluronic acid membranes: Effect of changes in matrix characteristics 1999 ·Journal of Controlled Release ·Laurent Simon, Valentino J. Stella, William N. Charman, Susan A. Charman	1
20	Presystemic acetylation of platelet cyclooxygenase: Selective inhibition by controlled release-low dose aspirin 1990 ·Journal of the American College of Cardiology ·Garret A. FitzGerald, (unknown), Susan A. Charman, William N. Charman	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact